A drug that boosts bone growth in children with achondroplasia may also reduce their chances of sudden infant death syndrome (SIDS), sleep apnoea and needing surgery, according to a new study. The international research trial, led by Murdoch Children’s Research Institute (MCRI) and published in The Lancet Child & Adolescent Health, has showed for the […]
Read More… from Drug may reduce SIDS in children with achondroplasia